Branch retinal vein occlusion
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Written informed consent 2. Male or female Chinese patients = 18 years of age with BRVO and 3. Visual impairment due to ME secondary to BRVO in at least one eye with BCVA score between 73 and 24 and at least 24 letters in the other eye.
Exclusion criteria
Exclusion criteria: 1. Unable to finish the follow-up visits; 2. Pregnant or nursing (lactating) women or women of child-bearing; 3. potential without using effective contraception; 4. Stroke or myocardial infarction less than 3 months prior to screening visit; 5. Renal failure OR creatinine levels > 2.0 mg/dl; 6. Uncontrolled hypertension; 7. Active ocular infection or intraocular inflammation in any eye; 8. Neovascularization of the iris or neovascular glaucoma in any eye; 9. History of uveitis or vitreomacular traction in any eye; 10. Treatment with any anti-angiogenic drugs within 3 months prior to baseline visit in any eye; 11. Glaucoma or IOP = 24 mmHg in study eye; 12. Active proliferative diabetic retinopathy in study eye; 13. Use of other investigational drugs within 30 days and systemic anti-VEGF drugs within 6 months prior to baseline visit; 14. Prior laser photocoagulation or intraocular procedure within 3 months; 15. prior to baseline in study eye; 16. History of intravitreal corticosteroid treatment in phakic study eye, and in aphakic or pseudophakic within 3 months prior to screening; 17. History of vitrectomy in study eye; 18. Other protocol defined inclusion /exclusion criteria may apply.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| best corrected visual acuity; | — |
Secondary
| Measure | Time frame |
|---|---|
| injections; | — |
Countries
China
Contacts
Beijing Hospital